Related Experiment Video
Updated: Aug 6, 2026

10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
Outcome after decompressive craniectomy in patients with severe ischemic stroke
S Harscher1, R Reichart, C Terborg
1Department of Neurology, Friedrich-Schiller-University Jena, Jena, Germany. Stefan.Harscher@med.uni-jena.de
Acta Neurochirurgica
|September 21, 2005
Summary
Decompressive craniectomy for space-occupying middle cerebral artery (MCA) infarction reduces mortality and improves outcomes. Age and comorbidities predict prognosis in these stroke patients.
Area of Science:
- Neurosurgery
- Neurology
- Critical Care Medicine
Background:
- Space-occupying middle cerebral artery (MCA) infarction presents a significant mortality risk.
- Decompressive craniectomy is a potential intervention to mitigate this risk.
- Predictors of prognosis following this procedure require further elucidation.
Purpose of the Study:
- To evaluate mortality rates and functional outcomes after decompressive craniectomy for MCA infarction.
- To identify prognostic predictors in patients undergoing this surgical intervention.
- To assess the efficacy of hemicraniectomy in a clinical setting.
Main Methods:
- Retrospective analysis of 30 patients undergoing craniectomy for MCA infarction (1996-2002).
- Assessment of functional outcome using Barthel Index, modified Rankin Scale, and extended Barthel Index.
- Correlation of mortality and functional outcome with patient age and comorbidities.
Main Results:
- Overall mortality was observed, with early deaths due to herniation and later deaths from complications.
- 16 patients survived with a mean follow-up of 2.1 years.
- Mortality was linked to advanced age and higher comorbidity burden; functional outcome also depended on comorbidities.
Conclusions:
- Decompressive craniectomy for space-occupying MCA infarction appears to decrease mortality and improve functional outcomes.
- Age and comorbidities are significant predictors of prognosis.
- Further randomized trials are warranted to confirm indications, timing, and refine prognostic understanding.

